Coles leaves NPS to take reins at Onyx

There's another game of musical chairs in biotech today. NPS Pharmaceuticals President and CEO Tony Coles is moving to take the reins at Onyx Pharmaceuticals. Onyx CEO Hollings Renton had announced plans to retire last October. He steps out officially at the end of March. NPS COO Francois Nader, meanwhile, is stepping up to the Coles' position. Nader joined NPS in 2006 and was promoted to COO last year.

- see this release
- read the AFX report

ALSO: Richard Eno was named CEO of Metabolix. Release

Related Articles:
NPS pockets $30M, parts ways with AstraZeneca. Report
Analyst puts NPS Pharma under microscope. Report
NPS sells drug rights. Report
NPS halves workforce in restructuring. Report